Frequency Therapeutics, Inc. (FREQ)
| Market Cap | 274.44M |
| Revenue (ttm) | 34.37M |
| Net Income (ttm) | -41.97M |
| Shares Out | 34.22M |
| EPS (ttm) | -1.27 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 29 |
| Last Price | $7.80 |
| Previous Close | $8.02 |
| Change ($) | -0.22 |
| Change (%) | -2.74% |
| Day's Open | 8.01 |
| Day's Range | 7.66 - 8.10 |
| Day's Volume | 88,264 |
| 52-Week Range | 7.34 - 58.37 |
Los Angeles, California--(Newsfile Corp. - July 29, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...
New York, New York--(Newsfile Corp. - July 29, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Frequency Therapeutics, Inc. (NAS...
NEW YORK, July 28, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ: FREQ) and certain ...
New York, New York--(Newsfile Corp. - July 28, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased Frequency Therapeutics, Inc...
New York, New York--(Newsfile Corp. - July 28, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Frequency Therapeutics, Inc. (NASDAQ: FREQ)...
Boston, Massachusetts--(Newsfile Corp. - July 28, 2021) - The Thornton Law Firm alerts investors who purchased Frequency Therapeutics, Inc. securities (NASDAQ: FREQ) between November 16, 2020 and March ...
New York, New York--(Newsfile Corp. - July 28, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Freq...
BENSALEM, Pa., July 28, 2021 /PRNewswire/ -- Law Offices of Howard G.
SAN DIEGO--(BUSINESS WIRE)-- #FREQstock--The suit alleges defendants issued false statements re Frequency Therapeutics business & prospects, resulting in its stock trading at inflated prices.
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...
Philadelphia, Pennsylvania--(Newsfile Corp. - July 27, 2021) - Berger Montague reminds investors of the upcoming deadline of August 2, 2021 for investors to seek lead plaintiff status in a securities fr...
Los Angeles, California--(Newsfile Corp. - July 27, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...
NEW YORK, July 26, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Frequency Therapeutics, Inc. (NASDAQ: FREQ) between November 16, 2...
San Diego, California--(Newsfile Corp. - July 26, 2021) - The Frequency Therapeutics, Inc. (NASDAQ: FREQ) class action lawsuit charges Frequency Therapeutics and its CEO with violations of the Securiti...
New York, New York--(Newsfile Corp. - July 26, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Frequency Therapeutics, Inc. (NASDAQ: FREQ)...
New York, New York--(Newsfile Corp. - July 26, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Fre...
Philadelphia, Pennsylvania--(Newsfile Corp. - July 26, 2021) - Berger Montague reminds investors of the upcoming deadline of August 2, 2021 for investors to seek lead plaintiff status in a securities fr...
Los Angeles, California--(Newsfile Corp. - July 26, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...
New York, New York--(Newsfile Corp. - July 23, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ: FRE...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...
LOS ANGELES, July 23, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming August 2, 2021 deadline to file a lead plaintiff motion in the class action filed on b...
Philadelphia, Pennsylvania--(Newsfile Corp. - July 23, 2021) - Berger Montague reminds investors of the upcoming deadline of August 2, 2021 for investors to seek lead plaintiff status in a securities fr...
Los Angeles, California--(Newsfile Corp. - July 23, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...
Boston, Massachusetts--(Newsfile Corp. - July 23, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Frequency Therapeutics, Inc. (NASDAQ...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...
New York, New York--(Newsfile Corp. - July 22, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Frequency Therapeutics, Inc. (NASDAQ: FREQ) ...
San Diego, California--(Newsfile Corp. - July 22, 2021) - The Frequency Therapeutics, Inc. class action lawsuit charges Frequency Therapeutics (NASDAQ: FREQ) and its CEO with violations of the Securitie...
Los Angeles, California--(Newsfile Corp. - July 22, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...
New York, New York--(Newsfile Corp. - July 21, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Frequency Therapeutics, Inc.Share...
San Diego, California and Woburn, Massachusetts--(Newsfile Corp. - July 21, 2021) - Shareholder rights law firm Robbins LLP reminds investors that a class action has been filed on behalf of all purchas...
New York, New York--(Newsfile Corp. - July 21, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Frequency Therapeut...
LOS ANGELES, July 21, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired F...
Los Angeles, California--(Newsfile Corp. - July 21, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...
New York, New York--(Newsfile Corp. - July 20, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Frequency Therapeutics, Inc. (NASDAQ: FREQ) between...
NEW YORK--(BUSINESS WIRE)-- #FREQ--INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Reminds Investors of a Securities Class Action Against Frequency, Inc. (NASDAQ: FREQ) and Deadline
Los Angeles, California--(Newsfile Corp. - July 20, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...
NEW YORK, July 18, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ: FREQ) and certain ...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...
NEW YORK--(BUSINESS WIRE)---- $FREQ--The law firm of Kirby McInerney LLP announces that a securities class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on b...
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Frequency Therapeutics, Inc. (NASDAQ: FREQ) between November 16, 2020 and March...
Los Angeles, California--(Newsfile Corp. - July 16, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...
New York, New York--(Newsfile Corp. - July 15, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Frequency Therapeuti...
Boston, Massachusetts--(Newsfile Corp. - July 15, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Frequency Therapeutics, Inc. (NASDAQ...
Los Angeles, California--(Newsfile Corp. - July 15, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...
New York, New York--(Newsfile Corp. - July 14, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Frequency Therapeutics, Inc. (NASDAQ: FREQ) between...
Los Angeles, California--(Newsfile Corp. - July 14, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...
New York, New York--(Newsfile Corp. - July 13, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ: FR...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...
About FREQ
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of... [Read more...]
| Industry Biotechnology | IPO Date Oct 3, 2019 |
| Stock Exchange NASDAQ | Ticker Symbol FREQ |
Financial Performance
In 2020, FREQ's revenue was $36.98 million, an increase of 27.76% compared to the previous year's $28.95 million. Losses were -$26.51 million, 41.4% more than in 2019.
Analyst Forecasts
According to 5 analysts, the average rating for FREQ stock is "Buy." The 12-month stock price forecast is 16.00, which is an increase of 105.13% from the latest price.